UPDATE: Credit Suisse Reiterates Neutral Rating, Raises PT on Aetna
In a report published Friday, Credit Suisse reiterated its Neutral rating on Aetna (NYSE: AET), and raised its price target from $43.00 to $48.00.
Credit Suisse noted, “AET reported 3Q12 operating EPS of $1.55, ahead of our/consensus $1.30/$1.34 and revised 2012 EPS guidance to $5.10, the high end of its previous range of $5.00 to $5.10. The upside was largely driven by lower cost trends and solid operating margins. While the company did not give 2013 guidance, it provided headwinds and tailwinds, and expects EPS to grow next year. We note that the CVH acquisition is expected to be modestly accretive to 2013 EPS and will reinforce AET's capital flexibility.”
Aetna closed on Thursday at $43.95.
Latest Ratings for AET
|Jan 2017||Leerink Swann||Downgrades||Outperform||Market Perform|
|Jan 2017||PiperJaffray||Initiates Coverage On||Neutral|
|Nov 2016||Credit Suisse||Upgrades||Neutral||Outperform|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.